trending Market Intelligence /marketintelligence/en/news-insights/trending/cS4jo6zlurG0iNbNaCUb0g2 content esgSubNav
In This List

AMS Life Science fiscal Q2 profit climbs 41.9% YOY

Podcast

Next in Tech | Episode 50: InfoSec spending up, again…

Blog

Broadcast deal market recap 2021

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Price wars in India: Disney+ Hotstar vs. Amazon Prime Video vs. Netflix


AMS Life Science fiscal Q2 profit climbs 41.9% YOY

AFC-HD AMS Life Science Co. Ltd. said its normalized net income for the fiscal second quarter ended Feb. 28 amounted to ¥8.38 per share, an increase of 38.6% from ¥6.04 per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥102.9 million, an increase of 41.9% from ¥72.5 million in the year-earlier period.

The normalized profit margin increased to 3.0% from 2.1% in the year-earlier period.

Total revenue totaled ¥3.41 billion, compared with ¥3.43 billion in the prior-year period, and total operating expenses decreased from the prior-year period to ¥3.23 billion from ¥3.30 billion.

Reported net income grew 51.0% from the prior-year period to ¥114.2 million, or ¥9.30 per share, from ¥75.6 million, or ¥6.30 per share.

As of April 14, US$1 was equivalent to ¥119.09.